Drug Shortage Report for CIPROFLOXACIN

Last updated on 2023-01-23 History
Report ID 152957
Drug Identification Number 02353326
Brand name CIPROFLOXACIN
Common or Proper name CIPROFLOXACIN
Company Name SANIS HEALTH INC
Market Status DORMANT
Active Ingredient(s) CIPROFLOXACIN
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-03-30
Actual start date 2022-04-15
Estimated end date 2023-01-20
Actual end date 2023-01-20
Shortage status Resolved
Updated date 2023-01-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2023-01-23 French Compare
v15 2023-01-23 English Compare
v14 2023-01-11 French Compare
v13 2023-01-11 English Compare
v12 2022-12-16 French Compare
v11 2022-12-16 English Compare
v10 2022-06-08 French Compare
v9 2022-06-08 English Compare
v8 2022-04-16 English Compare
v7 2022-04-05 French Compare
v6 2022-04-05 English Compare
v5 2022-03-31 English Compare
v4 2022-02-02 French Compare
v3 2022-02-02 English Compare
v2 2022-01-18 French Compare
v1 2022-01-18 English Compare

Showing 1 to 16 of 16